Employees: 11-50
Investment Type: Venture Capital
Persons 1
| Date | First Name | Last Name | Title | |||
| - | Tim | Van Treure... | Principal ... | - | - |
Mentions in press and media 9
| Date | Title | Description |
| 16.09.2024 | ONL Therapeutics Closes $65M Series D Financing | ONL Therapeutics, an Ann Arbor, MI-based clinical-stage biopharmaceutical company focused on advancing treatments of geographic atrophy (GA) associated with dry age-related macular degeneration (AMD), raised $65M in Series D funding. The ro... |
| 12.11.2019 | Actuate Therapeutics Completes $6.5 Million Series B-3 Financing | Actuate Therapeutics, Inc., a clinical stage biopharmaceutical company, today announced it has raised an additional $6.5M in a Series B-3 financing round. This Series B-3 was led by Bios Partners with Kairos Ventures, DEFTA Partners, and ot... |
| 23.07.2019 | Trefoil moves closer to a clinical trial: Announcing our follow on investment | Trefoil Therapeutics, Inc., an early-stage biopharmaceutical company and ExSight Ventures portfolio company, announced their $28 million Series A financing. Trefoil is developing a regenerative approach to treating corneal dystrophies and o... |
| 17.05.2019 | Actuate Therapeutics Completes $21.7M Series B Financing | Actuate Therapeutics, Inc., a clinical stage biopharmaceutical company, today announced it has raised $21.7 Million in a Series B financing round. The Series B is led by Kairos Ventures, with DEFTA Partners, Tech Coast Angels, and existing ... |
| 17.05.2019 | Actuate Therapeutics Completes $21.7M Series B Financing | Actuate Therapeutics, Inc., a clinical stage biopharmaceutical company, today announced it has raised $21.7 Million in a Series B financing round. The Series B is led by Kairos Ventures, with DEFTA Partners, Tech Coast Angels, and existing ... |
| 29.01.2018 | Bios Partners to Raise $50M Second Venture Capital Fund | Bios Partners, a Fort Worth, TX-based venture capital firm, is to raise its second fund. Per an SEC filing, BIOS Fund II NT, LP is seeking to raise $50m. Led by Aaron Fletcher and Leslie Kreis, Jr., Stella M. Robertson, Bios Partners focuse... |
| 24.01.2018 | Bios Partners Raises $50M Second Fund | Bios Partners in Fort Worth, Texas, has filed to raise a $50 million second fund, according to a regulatory filing. The filing for Bios Fund II NT lists Leslie Kries, Jr.and Aaron Fletcher as managing partners. Kreis is also listed as manag... |
| 23.01.2018 | Bios Partners Raises $50M Second Fund | Bios Partners in Fort Worth, Texas, has filed to raise a $50 million second fund, according to a regulatory filing. The filing for Bios Fund II NT lists Leslie Kries, Jr.and Aaron Fletcher as managing partners. Kreis is also listed as manag... |
| 08.06.2017 | Lung Therapeutics Raises $14.3M Series B | Lung Therapeutics, Inc., a clinical stage pharmaceutical company developing novel therapeutics for niche, orphan drug indications in fibrosis, lung injury and disease, announced today the successful completion of a $14.3 million Series B fi... |